nodes	percent_of_prediction	percent_of_DWPC	metapath
Nabilone—CNR2—breast cancer	0.717	1	CbGaD
Nabilone—Dronabinol—CNR2—breast cancer	0.00339	0.506	CrCbGaD
Nabilone—CNR1—mammary gland—breast cancer	0.00213	0.477	CbGeAlD
Nabilone—CNR1—adipose tissue—breast cancer	0.000957	0.215	CbGeAlD
Nabilone—Dronabinol—ABCG2—breast cancer	0.00093	0.139	CrCbGaD
Nabilone—CNR1—adrenal gland—breast cancer	0.000858	0.193	CbGeAlD
Nabilone—Dronabinol—PTGS1—breast cancer	0.000796	0.119	CrCbGaD
Nabilone—Dronabinol—CYP1A1—breast cancer	0.000728	0.109	CrCbGaD
Nabilone—CNR1—lymph node—breast cancer	0.000514	0.115	CbGeAlD
Nabilone—Dronabinol—CYP3A4—breast cancer	0.000465	0.0694	CrCbGaD
Nabilone—Dronabinol—ABCB1—breast cancer	0.000387	0.0578	CrCbGaD
Nabilone—CNR1—Signaling Pathways—HIST1H2BC—breast cancer	6.2e-05	0.000675	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—HIST1H2BK—breast cancer	6.2e-05	0.000675	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—THBS1—breast cancer	6.19e-05	0.000674	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—GRB7—breast cancer	6.15e-05	0.000669	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PDE4D—breast cancer	6.15e-05	0.000669	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—CSF2—breast cancer	6.12e-05	0.000666	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—TAB2—breast cancer	6.04e-05	0.000657	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—ITPR1—breast cancer	6.02e-05	0.000655	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CNR2—breast cancer	5.99e-05	0.000652	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—CXCL8—breast cancer	5.99e-05	0.000652	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—MMP3—breast cancer	5.98e-05	0.00065	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—FLT1—breast cancer	5.91e-05	0.000643	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—FGF3—breast cancer	5.88e-05	0.00064	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—SQSTM1—breast cancer	5.88e-05	0.00064	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—PIK3CG—breast cancer	5.85e-05	0.000637	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—DKK1—breast cancer	5.85e-05	0.000636	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—JAG1—breast cancer	5.81e-05	0.000632	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—VEGFC—breast cancer	5.8e-05	0.000631	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—NOTCH3—breast cancer	5.78e-05	0.00063	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PARP1—breast cancer	5.78e-05	0.00063	CbGpPWpGaD
Nabilone—Tachycardia—Capecitabine—breast cancer	5.75e-05	0.000319	CcSEcCtD
Nabilone—Hypoaesthesia—Epirubicin—breast cancer	5.75e-05	0.000319	CcSEcCtD
Nabilone—Pharyngitis—Epirubicin—breast cancer	5.73e-05	0.000318	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—CALCA—breast cancer	5.71e-05	0.000622	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—JAG2—breast cancer	5.71e-05	0.000622	CbGpPWpGaD
Nabilone—Hyperhidrosis—Capecitabine—breast cancer	5.69e-05	0.000316	CcSEcCtD
Nabilone—Hypotension—Docetaxel—breast cancer	5.68e-05	0.000316	CcSEcCtD
Nabilone—Abdominal pain—Paclitaxel—breast cancer	5.67e-05	0.000315	CcSEcCtD
Nabilone—Body temperature increased—Paclitaxel—breast cancer	5.67e-05	0.000315	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—RPS6—breast cancer	5.65e-05	0.000615	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—WNT1—breast cancer	5.63e-05	0.000613	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—PLA2G4A—breast cancer	5.62e-05	0.000612	CbGpPWpGaD
Nabilone—Epistaxis—Doxorubicin—breast cancer	5.62e-05	0.000312	CcSEcCtD
Nabilone—Anorexia—Capecitabine—breast cancer	5.61e-05	0.000312	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—FGF4—breast cancer	5.6e-05	0.00061	CbGpPWpGaD
Nabilone—Vomiting—Mitoxantrone—breast cancer	5.6e-05	0.000311	CcSEcCtD
Nabilone—Vomiting—Irinotecan—breast cancer	5.6e-05	0.000311	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—CXCL12—breast cancer	5.58e-05	0.000607	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CXCR4—breast cancer	5.58e-05	0.000607	CbGpPWpGaD
Nabilone—Dizziness—Fluorouracil—breast cancer	5.57e-05	0.00031	CcSEcCtD
Nabilone—Visual impairment—Epirubicin—breast cancer	5.57e-05	0.000309	CcSEcCtD
Nabilone—CNR1—Signaling by GPCR—CSF2—breast cancer	5.56e-05	0.000605	CbGpPWpGaD
Nabilone—Rash—Mitoxantrone—breast cancer	5.55e-05	0.000308	CcSEcCtD
Nabilone—Rash—Irinotecan—breast cancer	5.55e-05	0.000308	CcSEcCtD
Nabilone—Dermatitis—Irinotecan—breast cancer	5.54e-05	0.000308	CcSEcCtD
Nabilone—Dermatitis—Mitoxantrone—breast cancer	5.54e-05	0.000308	CcSEcCtD
Nabilone—Musculoskeletal discomfort—Docetaxel—breast cancer	5.54e-05	0.000308	CcSEcCtD
Nabilone—Chills—Methotrexate—breast cancer	5.54e-05	0.000308	CcSEcCtD
Nabilone—Headache—Mitoxantrone—breast cancer	5.51e-05	0.000306	CcSEcCtD
Nabilone—Headache—Irinotecan—breast cancer	5.51e-05	0.000306	CcSEcCtD
Nabilone—Hypotension—Capecitabine—breast cancer	5.5e-05	0.000306	CcSEcCtD
Nabilone—Insomnia—Docetaxel—breast cancer	5.5e-05	0.000306	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—PAK1—breast cancer	5.48e-05	0.000596	CbGpPWpGaD
Nabilone—Paraesthesia—Docetaxel—breast cancer	5.46e-05	0.000303	CcSEcCtD
Nabilone—Vomiting—Gemcitabine—breast cancer	5.45e-05	0.000303	CcSEcCtD
Nabilone—Dyspnoea—Docetaxel—breast cancer	5.42e-05	0.000301	CcSEcCtD
Nabilone—Somnolence—Docetaxel—breast cancer	5.41e-05	0.0003	CcSEcCtD
Nabilone—Rash—Gemcitabine—breast cancer	5.41e-05	0.0003	CcSEcCtD
Nabilone—Dermatitis—Gemcitabine—breast cancer	5.4e-05	0.0003	CcSEcCtD
Nabilone—Eye disorder—Epirubicin—breast cancer	5.4e-05	0.0003	CcSEcCtD
Nabilone—Tinnitus—Epirubicin—breast cancer	5.39e-05	0.000299	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—TCF7L2—breast cancer	5.38e-05	0.000586	CbGpPWpGaD
Nabilone—Headache—Gemcitabine—breast cancer	5.37e-05	0.000298	CcSEcCtD
Nabilone—Musculoskeletal discomfort—Capecitabine—breast cancer	5.37e-05	0.000298	CcSEcCtD
Nabilone—Flushing—Epirubicin—breast cancer	5.36e-05	0.000298	CcSEcCtD
Nabilone—Vomiting—Fluorouracil—breast cancer	5.36e-05	0.000298	CcSEcCtD
Nabilone—CNR2—GPCR downstream signaling—AKT2—breast cancer	5.36e-05	0.000583	CbGpPWpGaD
Nabilone—Dyspepsia—Docetaxel—breast cancer	5.36e-05	0.000297	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—NOTCH4—breast cancer	5.34e-05	0.000581	CbGpPWpGaD
Nabilone—Insomnia—Capecitabine—breast cancer	5.33e-05	0.000296	CcSEcCtD
Nabilone—Hypoaesthesia—Doxorubicin—breast cancer	5.32e-05	0.000295	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—PIK3CG—breast cancer	5.32e-05	0.000579	CbGpPWpGaD
Nabilone—Rash—Fluorouracil—breast cancer	5.31e-05	0.000295	CcSEcCtD
Nabilone—Dermatitis—Fluorouracil—breast cancer	5.31e-05	0.000295	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—GZMB—breast cancer	5.31e-05	0.000577	CbGpPWpGaD
Nabilone—Pharyngitis—Doxorubicin—breast cancer	5.3e-05	0.000295	CcSEcCtD
Nabilone—Paraesthesia—Capecitabine—breast cancer	5.29e-05	0.000294	CcSEcCtD
Nabilone—Decreased appetite—Docetaxel—breast cancer	5.29e-05	0.000294	CcSEcCtD
Nabilone—Hypersensitivity—Paclitaxel—breast cancer	5.29e-05	0.000294	CcSEcCtD
Nabilone—Headache—Fluorouracil—breast cancer	5.28e-05	0.000293	CcSEcCtD
Nabilone—Dyspnoea—Capecitabine—breast cancer	5.25e-05	0.000292	CcSEcCtD
Nabilone—Fatigue—Docetaxel—breast cancer	5.25e-05	0.000291	CcSEcCtD
Nabilone—Nausea—Irinotecan—breast cancer	5.23e-05	0.00029	CcSEcCtD
Nabilone—Nausea—Mitoxantrone—breast cancer	5.23e-05	0.00029	CcSEcCtD
Nabilone—Constipation—Docetaxel—breast cancer	5.2e-05	0.000289	CcSEcCtD
Nabilone—Pain—Docetaxel—breast cancer	5.2e-05	0.000289	CcSEcCtD
Nabilone—Back pain—Methotrexate—breast cancer	5.2e-05	0.000289	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—HSP90AA1—breast cancer	5.19e-05	0.000565	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—NOTCH2—breast cancer	5.19e-05	0.000565	CbGpPWpGaD
Nabilone—Dyspepsia—Capecitabine—breast cancer	5.18e-05	0.000288	CcSEcCtD
Nabilone—Chills—Epirubicin—breast cancer	5.18e-05	0.000288	CcSEcCtD
Nabilone—Arrhythmia—Epirubicin—breast cancer	5.16e-05	0.000287	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—CXCL2—breast cancer	5.15e-05	0.000561	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—AGTR2—breast cancer	5.15e-05	0.000561	CbGpPWpGaD
Nabilone—Visual impairment—Doxorubicin—breast cancer	5.15e-05	0.000286	CcSEcCtD
Nabilone—Asthenia—Paclitaxel—breast cancer	5.15e-05	0.000286	CcSEcCtD
Nabilone—CNR2—GPCR downstream signaling—PIK3CD—breast cancer	5.15e-05	0.00056	CbGpPWpGaD
Nabilone—Decreased appetite—Capecitabine—breast cancer	5.12e-05	0.000284	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—PTHLH—breast cancer	5.09e-05	0.000554	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—BMP2—breast cancer	5.09e-05	0.000554	CbGpPWpGaD
Nabilone—Nausea—Gemcitabine—breast cancer	5.09e-05	0.000283	CcSEcCtD
Nabilone—Fatigue—Capecitabine—breast cancer	5.08e-05	0.000282	CcSEcCtD
Nabilone—Pruritus—Paclitaxel—breast cancer	5.08e-05	0.000282	CcSEcCtD
Nabilone—Vision blurred—Methotrexate—breast cancer	5.06e-05	0.000281	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—PRL—breast cancer	5.05e-05	0.000549	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—AGTR1—breast cancer	5.05e-05	0.000549	CbGpPWpGaD
Nabilone—Constipation—Capecitabine—breast cancer	5.04e-05	0.00028	CcSEcCtD
Nabilone—Pain—Capecitabine—breast cancer	5.04e-05	0.00028	CcSEcCtD
Nabilone—Feeling abnormal—Docetaxel—breast cancer	5.01e-05	0.000278	CcSEcCtD
Nabilone—Nausea—Fluorouracil—breast cancer	5.01e-05	0.000278	CcSEcCtD
Nabilone—Eye disorder—Doxorubicin—breast cancer	4.99e-05	0.000277	CcSEcCtD
Nabilone—Ill-defined disorder—Methotrexate—breast cancer	4.98e-05	0.000277	CcSEcCtD
Nabilone—Tinnitus—Doxorubicin—breast cancer	4.98e-05	0.000277	CcSEcCtD
Nabilone—Gastrointestinal pain—Docetaxel—breast cancer	4.97e-05	0.000276	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—ADAM10—breast cancer	4.97e-05	0.000541	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—STK11—breast cancer	4.97e-05	0.000541	CbGpPWpGaD
Nabilone—Anaemia—Methotrexate—breast cancer	4.97e-05	0.000276	CcSEcCtD
Nabilone—Flushing—Doxorubicin—breast cancer	4.96e-05	0.000276	CcSEcCtD
Nabilone—Tension—Epirubicin—breast cancer	4.93e-05	0.000274	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—EDNRB—breast cancer	4.93e-05	0.000537	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PLG—breast cancer	4.92e-05	0.000535	CbGpPWpGaD
Nabilone—Diarrhoea—Paclitaxel—breast cancer	4.91e-05	0.000273	CcSEcCtD
Nabilone—Nervousness—Epirubicin—breast cancer	4.88e-05	0.000271	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—PGR—breast cancer	4.88e-05	0.000531	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—AKT2—breast cancer	4.86e-05	0.000529	CbGpPWpGaD
Nabilone—Back pain—Epirubicin—breast cancer	4.86e-05	0.00027	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—THBS1—breast cancer	4.86e-05	0.000529	CbGpPWpGaD
Nabilone—Feeling abnormal—Capecitabine—breast cancer	4.85e-05	0.00027	CcSEcCtD
Nabilone—Malaise—Methotrexate—breast cancer	4.85e-05	0.000269	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—FGF10—breast cancer	4.84e-05	0.000527	CbGpPWpGaD
Nabilone—Vertigo—Methotrexate—breast cancer	4.83e-05	0.000268	CcSEcCtD
Nabilone—Gastrointestinal pain—Capecitabine—breast cancer	4.82e-05	0.000268	CcSEcCtD
Nabilone—Abdominal pain—Docetaxel—breast cancer	4.81e-05	0.000267	CcSEcCtD
Nabilone—Body temperature increased—Docetaxel—breast cancer	4.81e-05	0.000267	CcSEcCtD
Nabilone—Leukopenia—Methotrexate—breast cancer	4.81e-05	0.000267	CcSEcCtD
Nabilone—Chills—Doxorubicin—breast cancer	4.8e-05	0.000266	CcSEcCtD
Nabilone—Arrhythmia—Doxorubicin—breast cancer	4.77e-05	0.000265	CcSEcCtD
Nabilone—Dizziness—Paclitaxel—breast cancer	4.75e-05	0.000264	CcSEcCtD
Nabilone—Vision blurred—Epirubicin—breast cancer	4.74e-05	0.000263	CcSEcCtD
Nabilone—Cough—Methotrexate—breast cancer	4.69e-05	0.00026	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—PIK3CD—breast cancer	4.67e-05	0.000509	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PDGFA—breast cancer	4.67e-05	0.000508	CbGpPWpGaD
Nabilone—Ill-defined disorder—Epirubicin—breast cancer	4.67e-05	0.000259	CcSEcCtD
Nabilone—Abdominal pain—Capecitabine—breast cancer	4.66e-05	0.000259	CcSEcCtD
Nabilone—Body temperature increased—Capecitabine—breast cancer	4.66e-05	0.000259	CcSEcCtD
Nabilone—Convulsion—Methotrexate—breast cancer	4.65e-05	0.000259	CcSEcCtD
Nabilone—Anaemia—Epirubicin—breast cancer	4.65e-05	0.000258	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—FLT1—breast cancer	4.64e-05	0.000505	CbGpPWpGaD
Nabilone—Agitation—Epirubicin—breast cancer	4.62e-05	0.000257	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—FGF3—breast cancer	4.62e-05	0.000503	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—SQSTM1—breast cancer	4.62e-05	0.000503	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—TGFBR2—breast cancer	4.6e-05	0.000501	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—PIK3CG—breast cancer	4.59e-05	0.0005	CbGpPWpGaD
Nabilone—Arthralgia—Methotrexate—breast cancer	4.57e-05	0.000254	CcSEcCtD
Nabilone—Myalgia—Methotrexate—breast cancer	4.57e-05	0.000254	CcSEcCtD
Nabilone—Chest pain—Methotrexate—breast cancer	4.57e-05	0.000254	CcSEcCtD
Nabilone—Tension—Doxorubicin—breast cancer	4.57e-05	0.000254	CcSEcCtD
Nabilone—Vomiting—Paclitaxel—breast cancer	4.56e-05	0.000254	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—JAG1—breast cancer	4.56e-05	0.000496	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—NOTCH3—breast cancer	4.54e-05	0.000494	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PARP1—breast cancer	4.54e-05	0.000494	CbGpPWpGaD
Nabilone—Malaise—Epirubicin—breast cancer	4.53e-05	0.000252	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—ITPR1—breast cancer	4.53e-05	0.000493	CbGpPWpGaD
Nabilone—Rash—Paclitaxel—breast cancer	4.53e-05	0.000251	CcSEcCtD
Nabilone—Dermatitis—Paclitaxel—breast cancer	4.52e-05	0.000251	CcSEcCtD
Nabilone—Discomfort—Methotrexate—breast cancer	4.52e-05	0.000251	CcSEcCtD
Nabilone—Nervousness—Doxorubicin—breast cancer	4.52e-05	0.000251	CcSEcCtD
Nabilone—Vertigo—Epirubicin—breast cancer	4.52e-05	0.000251	CcSEcCtD
Nabilone—Syncope—Epirubicin—breast cancer	4.51e-05	0.00025	CcSEcCtD
Nabilone—Leukopenia—Epirubicin—breast cancer	4.5e-05	0.00025	CcSEcCtD
Nabilone—Back pain—Doxorubicin—breast cancer	4.5e-05	0.00025	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—STAT5A—breast cancer	4.5e-05	0.00049	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—ERBB4—breast cancer	4.5e-05	0.00049	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—MMP3—breast cancer	4.5e-05	0.00049	CbGpPWpGaD
Nabilone—Headache—Paclitaxel—breast cancer	4.5e-05	0.00025	CcSEcCtD
Nabilone—CNR2—GPCR downstream signaling—PIK3CB—breast cancer	4.49e-05	0.000488	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CALCA—breast cancer	4.48e-05	0.000488	CbGpPWpGaD
Nabilone—Hypersensitivity—Docetaxel—breast cancer	4.48e-05	0.000249	CcSEcCtD
Nabilone—Palpitations—Epirubicin—breast cancer	4.44e-05	0.000247	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—RPS6—breast cancer	4.43e-05	0.000482	CbGpPWpGaD
Nabilone—Confusional state—Methotrexate—breast cancer	4.42e-05	0.000246	CcSEcCtD
Nabilone—Loss of consciousness—Epirubicin—breast cancer	4.42e-05	0.000245	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—FGF4—breast cancer	4.4e-05	0.000479	CbGpPWpGaD
Nabilone—Cough—Epirubicin—breast cancer	4.39e-05	0.000244	CcSEcCtD
Nabilone—Vision blurred—Doxorubicin—breast cancer	4.38e-05	0.000244	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—CXCR4—breast cancer	4.38e-05	0.000477	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CXCL12—breast cancer	4.38e-05	0.000477	CbGpPWpGaD
Nabilone—Asthenia—Docetaxel—breast cancer	4.36e-05	0.000242	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—SMAD4—breast cancer	4.36e-05	0.000474	CbGpPWpGaD
Nabilone—Convulsion—Epirubicin—breast cancer	4.36e-05	0.000242	CcSEcCtD
Nabilone—Infection—Methotrexate—breast cancer	4.36e-05	0.000242	CcSEcCtD
Nabilone—Hypertension—Epirubicin—breast cancer	4.34e-05	0.000241	CcSEcCtD
Nabilone—Hypersensitivity—Capecitabine—breast cancer	4.34e-05	0.000241	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—IGF1R—breast cancer	4.33e-05	0.000471	CbGpPWpGaD
Nabilone—Ill-defined disorder—Doxorubicin—breast cancer	4.32e-05	0.00024	CcSEcCtD
Nabilone—CNR2—GPCR downstream signaling—CXCL8—breast cancer	4.31e-05	0.000469	CbGpPWpGaD
Nabilone—Pruritus—Docetaxel—breast cancer	4.3e-05	0.000239	CcSEcCtD
Nabilone—Anaemia—Doxorubicin—breast cancer	4.3e-05	0.000239	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—PAK1—breast cancer	4.3e-05	0.000468	CbGpPWpGaD
Nabilone—Myalgia—Epirubicin—breast cancer	4.28e-05	0.000238	CcSEcCtD
Nabilone—Arthralgia—Epirubicin—breast cancer	4.28e-05	0.000238	CcSEcCtD
Nabilone—Chest pain—Epirubicin—breast cancer	4.28e-05	0.000238	CcSEcCtD
Nabilone—Agitation—Doxorubicin—breast cancer	4.28e-05	0.000237	CcSEcCtD
Nabilone—Anxiety—Epirubicin—breast cancer	4.27e-05	0.000237	CcSEcCtD
Nabilone—Nausea—Paclitaxel—breast cancer	4.26e-05	0.000237	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—HES1—breast cancer	4.25e-05	0.000463	CbGpPWpGaD
Nabilone—Hyperhidrosis—Methotrexate—breast cancer	4.24e-05	0.000235	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—NCOR1—breast cancer	4.23e-05	0.00046	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PLA2G4A—breast cancer	4.23e-05	0.00046	CbGpPWpGaD
Nabilone—Discomfort—Epirubicin—breast cancer	4.23e-05	0.000235	CcSEcCtD
Nabilone—Asthenia—Capecitabine—breast cancer	4.23e-05	0.000235	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—TCF7L2—breast cancer	4.22e-05	0.00046	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—AKT2—breast cancer	4.2e-05	0.000458	CbGpPWpGaD
Nabilone—Malaise—Doxorubicin—breast cancer	4.2e-05	0.000233	CcSEcCtD
Nabilone—Dry mouth—Epirubicin—breast cancer	4.19e-05	0.000233	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—FGF1—breast cancer	4.18e-05	0.000455	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CSF2—breast cancer	4.18e-05	0.000455	CbGpPWpGaD
Nabilone—Vertigo—Doxorubicin—breast cancer	4.18e-05	0.000232	CcSEcCtD
Nabilone—Anorexia—Methotrexate—breast cancer	4.18e-05	0.000232	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—RAF1—breast cancer	4.17e-05	0.000454	CbGpPWpGaD
Nabilone—Syncope—Doxorubicin—breast cancer	4.17e-05	0.000232	CcSEcCtD
Nabilone—CNR1—Signaling by GPCR—PIK3CG—breast cancer	4.17e-05	0.000454	CbGpPWpGaD
Nabilone—Pruritus—Capecitabine—breast cancer	4.17e-05	0.000231	CcSEcCtD
Nabilone—Leukopenia—Doxorubicin—breast cancer	4.16e-05	0.000231	CcSEcCtD
Nabilone—Diarrhoea—Docetaxel—breast cancer	4.16e-05	0.000231	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—NRG1—breast cancer	4.15e-05	0.000452	CbGpPWpGaD
Nabilone—Confusional state—Epirubicin—breast cancer	4.14e-05	0.00023	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—H2AFX—breast cancer	4.12e-05	0.000449	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—IL2—breast cancer	4.12e-05	0.000448	CbGpPWpGaD
Nabilone—Palpitations—Doxorubicin—breast cancer	4.11e-05	0.000228	CcSEcCtD
Nabilone—Hypotension—Methotrexate—breast cancer	4.1e-05	0.000228	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—E2F1—breast cancer	4.09e-05	0.000445	CbGpPWpGaD
Nabilone—Loss of consciousness—Doxorubicin—breast cancer	4.09e-05	0.000227	CcSEcCtD
Nabilone—Infection—Epirubicin—breast cancer	4.08e-05	0.000226	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—PIK3CB—breast cancer	4.07e-05	0.000443	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—HSP90AA1—breast cancer	4.07e-05	0.000443	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—NOTCH2—breast cancer	4.07e-05	0.000443	CbGpPWpGaD
Nabilone—Cough—Doxorubicin—breast cancer	4.06e-05	0.000226	CcSEcCtD
Nabilone—CNR1—GPCR downstream signaling—PIK3CD—breast cancer	4.04e-05	0.00044	CbGpPWpGaD
Nabilone—Shock—Epirubicin—breast cancer	4.04e-05	0.000224	CcSEcCtD
Nabilone—Convulsion—Doxorubicin—breast cancer	4.03e-05	0.000224	CcSEcCtD
Nabilone—Diarrhoea—Capecitabine—breast cancer	4.03e-05	0.000224	CcSEcCtD
Nabilone—Dizziness—Docetaxel—breast cancer	4.02e-05	0.000223	CcSEcCtD
Nabilone—Hypertension—Doxorubicin—breast cancer	4.02e-05	0.000223	CcSEcCtD
Nabilone—Tachycardia—Epirubicin—breast cancer	4e-05	0.000222	CcSEcCtD
Nabilone—Musculoskeletal discomfort—Methotrexate—breast cancer	3.99e-05	0.000222	CcSEcCtD
Nabilone—Hyperhidrosis—Epirubicin—breast cancer	3.97e-05	0.00022	CcSEcCtD
Nabilone—Insomnia—Methotrexate—breast cancer	3.97e-05	0.00022	CcSEcCtD
Nabilone—Myalgia—Doxorubicin—breast cancer	3.96e-05	0.00022	CcSEcCtD
Nabilone—Chest pain—Doxorubicin—breast cancer	3.96e-05	0.00022	CcSEcCtD
Nabilone—Arthralgia—Doxorubicin—breast cancer	3.96e-05	0.00022	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—PRL—breast cancer	3.96e-05	0.000431	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—AGTR1—breast cancer	3.96e-05	0.000431	CbGpPWpGaD
Nabilone—Anxiety—Doxorubicin—breast cancer	3.95e-05	0.000219	CcSEcCtD
Nabilone—Paraesthesia—Methotrexate—breast cancer	3.94e-05	0.000219	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—SPP1—breast cancer	3.93e-05	0.000428	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—CXCL8—breast cancer	3.91e-05	0.000426	CbGpPWpGaD
Nabilone—Discomfort—Doxorubicin—breast cancer	3.91e-05	0.000217	CcSEcCtD
Nabilone—Anorexia—Epirubicin—breast cancer	3.91e-05	0.000217	CcSEcCtD
Nabilone—Dyspnoea—Methotrexate—breast cancer	3.91e-05	0.000217	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—STK11—breast cancer	3.9e-05	0.000425	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—ADAM10—breast cancer	3.9e-05	0.000425	CbGpPWpGaD
Nabilone—Somnolence—Methotrexate—breast cancer	3.9e-05	0.000217	CcSEcCtD
Nabilone—Dizziness—Capecitabine—breast cancer	3.9e-05	0.000216	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—ERBB3—breast cancer	3.89e-05	0.000423	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—FGFR2—breast cancer	3.88e-05	0.000423	CbGpPWpGaD
Nabilone—Dry mouth—Doxorubicin—breast cancer	3.87e-05	0.000215	CcSEcCtD
Nabilone—Vomiting—Docetaxel—breast cancer	3.87e-05	0.000215	CcSEcCtD
Nabilone—Dyspepsia—Methotrexate—breast cancer	3.86e-05	0.000214	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—PLG—breast cancer	3.86e-05	0.00042	CbGpPWpGaD
Nabilone—Rash—Docetaxel—breast cancer	3.84e-05	0.000213	CcSEcCtD
Nabilone—Hypotension—Epirubicin—breast cancer	3.83e-05	0.000213	CcSEcCtD
Nabilone—Dermatitis—Docetaxel—breast cancer	3.83e-05	0.000213	CcSEcCtD
Nabilone—Confusional state—Doxorubicin—breast cancer	3.83e-05	0.000213	CcSEcCtD
Nabilone—CNR1—Signaling by GPCR—AKT2—breast cancer	3.82e-05	0.000415	CbGpPWpGaD
Nabilone—Decreased appetite—Methotrexate—breast cancer	3.81e-05	0.000212	CcSEcCtD
Nabilone—Headache—Docetaxel—breast cancer	3.81e-05	0.000212	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—FGF10—breast cancer	3.8e-05	0.000413	CbGpPWpGaD
Nabilone—Fatigue—Methotrexate—breast cancer	3.78e-05	0.00021	CcSEcCtD
Nabilone—Infection—Doxorubicin—breast cancer	3.77e-05	0.00021	CcSEcCtD
Nabilone—Pain—Methotrexate—breast cancer	3.75e-05	0.000208	CcSEcCtD
Nabilone—Vomiting—Capecitabine—breast cancer	3.75e-05	0.000208	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—IL2—breast cancer	3.74e-05	0.000407	CbGpPWpGaD
Nabilone—Musculoskeletal discomfort—Epirubicin—breast cancer	3.74e-05	0.000208	CcSEcCtD
Nabilone—Shock—Doxorubicin—breast cancer	3.74e-05	0.000208	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—TERT—breast cancer	3.73e-05	0.000406	CbGpPWpGaD
Nabilone—Rash—Capecitabine—breast cancer	3.71e-05	0.000206	CcSEcCtD
Nabilone—Insomnia—Epirubicin—breast cancer	3.71e-05	0.000206	CcSEcCtD
Nabilone—Dermatitis—Capecitabine—breast cancer	3.71e-05	0.000206	CcSEcCtD
Nabilone—Tachycardia—Doxorubicin—breast cancer	3.71e-05	0.000206	CcSEcCtD
Nabilone—Headache—Capecitabine—breast cancer	3.69e-05	0.000205	CcSEcCtD
Nabilone—Paraesthesia—Epirubicin—breast cancer	3.68e-05	0.000205	CcSEcCtD
Nabilone—Hyperhidrosis—Doxorubicin—breast cancer	3.67e-05	0.000204	CcSEcCtD
Nabilone—CNR1—Signaling by GPCR—PIK3CD—breast cancer	3.67e-05	0.000399	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PDGFA—breast cancer	3.66e-05	0.000399	CbGpPWpGaD
Nabilone—Dyspnoea—Epirubicin—breast cancer	3.66e-05	0.000203	CcSEcCtD
Nabilone—Somnolence—Epirubicin—breast cancer	3.65e-05	0.000203	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—FGFR1—breast cancer	3.62e-05	0.000394	CbGpPWpGaD
Nabilone—Anorexia—Doxorubicin—breast cancer	3.62e-05	0.000201	CcSEcCtD
Nabilone—Nausea—Docetaxel—breast cancer	3.61e-05	0.000201	CcSEcCtD
Nabilone—Feeling abnormal—Methotrexate—breast cancer	3.61e-05	0.000201	CcSEcCtD
Nabilone—Dyspepsia—Epirubicin—breast cancer	3.61e-05	0.000201	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—TGFBR2—breast cancer	3.61e-05	0.000393	CbGpPWpGaD
Nabilone—Gastrointestinal pain—Methotrexate—breast cancer	3.59e-05	0.000199	CcSEcCtD
Nabilone—Decreased appetite—Epirubicin—breast cancer	3.57e-05	0.000198	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—HIF1A—breast cancer	3.56e-05	0.000388	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—ITPR1—breast cancer	3.55e-05	0.000387	CbGpPWpGaD
Nabilone—Hypotension—Doxorubicin—breast cancer	3.55e-05	0.000197	CcSEcCtD
Nabilone—Fatigue—Epirubicin—breast cancer	3.54e-05	0.000197	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—ERBB4—breast cancer	3.53e-05	0.000384	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—STAT5A—breast cancer	3.53e-05	0.000384	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—MMP3—breast cancer	3.53e-05	0.000384	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—PIK3CB—breast cancer	3.52e-05	0.000383	CbGpPWpGaD
Nabilone—Constipation—Epirubicin—breast cancer	3.51e-05	0.000195	CcSEcCtD
Nabilone—Pain—Epirubicin—breast cancer	3.51e-05	0.000195	CcSEcCtD
Nabilone—Nausea—Capecitabine—breast cancer	3.5e-05	0.000194	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—LEP—breast cancer	3.48e-05	0.000379	CbGpPWpGaD
Nabilone—Body temperature increased—Methotrexate—breast cancer	3.47e-05	0.000193	CcSEcCtD
Nabilone—Abdominal pain—Methotrexate—breast cancer	3.47e-05	0.000193	CcSEcCtD
Nabilone—Musculoskeletal discomfort—Doxorubicin—breast cancer	3.46e-05	0.000192	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—CAV1—breast cancer	3.45e-05	0.000375	CbGpPWpGaD
Nabilone—Insomnia—Doxorubicin—breast cancer	3.43e-05	0.000191	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—SMAD4—breast cancer	3.42e-05	0.000372	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—KDR—breast cancer	3.41e-05	0.000371	CbGpPWpGaD
Nabilone—Paraesthesia—Doxorubicin—breast cancer	3.41e-05	0.000189	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—IGF1R—breast cancer	3.4e-05	0.00037	CbGpPWpGaD
Nabilone—Dyspnoea—Doxorubicin—breast cancer	3.39e-05	0.000188	CcSEcCtD
Nabilone—CNR1—GPCR downstream signaling—CXCL8—breast cancer	3.38e-05	0.000368	CbGpPWpGaD
Nabilone—Feeling abnormal—Epirubicin—breast cancer	3.38e-05	0.000188	CcSEcCtD
Nabilone—Somnolence—Doxorubicin—breast cancer	3.38e-05	0.000188	CcSEcCtD
Nabilone—Gastrointestinal pain—Epirubicin—breast cancer	3.36e-05	0.000186	CcSEcCtD
Nabilone—Dyspepsia—Doxorubicin—breast cancer	3.34e-05	0.000186	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—HES1—breast cancer	3.34e-05	0.000363	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—ESR1—breast cancer	3.32e-05	0.000362	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—NCOR1—breast cancer	3.32e-05	0.000361	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PLA2G4A—breast cancer	3.32e-05	0.000361	CbGpPWpGaD
Nabilone—Decreased appetite—Doxorubicin—breast cancer	3.3e-05	0.000183	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—FN1—breast cancer	3.28e-05	0.000357	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CSF2—breast cancer	3.28e-05	0.000357	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—FGF1—breast cancer	3.28e-05	0.000357	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—RAF1—breast cancer	3.27e-05	0.000356	CbGpPWpGaD
Nabilone—Fatigue—Doxorubicin—breast cancer	3.27e-05	0.000182	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—NRG1—breast cancer	3.26e-05	0.000355	CbGpPWpGaD
Nabilone—Constipation—Doxorubicin—breast cancer	3.25e-05	0.00018	CcSEcCtD
Nabilone—Pain—Doxorubicin—breast cancer	3.25e-05	0.00018	CcSEcCtD
Nabilone—Body temperature increased—Epirubicin—breast cancer	3.24e-05	0.00018	CcSEcCtD
Nabilone—Abdominal pain—Epirubicin—breast cancer	3.24e-05	0.00018	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—NFKBIA—breast cancer	3.24e-05	0.000353	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—H2AFX—breast cancer	3.23e-05	0.000352	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—IL2—breast cancer	3.23e-05	0.000352	CbGpPWpGaD
Nabilone—Hypersensitivity—Methotrexate—breast cancer	3.23e-05	0.000179	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—NOTCH1—breast cancer	3.21e-05	0.00035	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—E2F1—breast cancer	3.21e-05	0.00035	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—PIK3CB—breast cancer	3.2e-05	0.000348	CbGpPWpGaD
Nabilone—Asthenia—Methotrexate—breast cancer	3.15e-05	0.000175	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—KIT—breast cancer	3.14e-05	0.000342	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PIK3CG—breast cancer	3.14e-05	0.000342	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—APC—breast cancer	3.14e-05	0.000342	CbGpPWpGaD
Nabilone—Feeling abnormal—Doxorubicin—breast cancer	3.13e-05	0.000174	CcSEcCtD
Nabilone—Gastrointestinal pain—Doxorubicin—breast cancer	3.1e-05	0.000172	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—EGF—breast cancer	3.1e-05	0.000338	CbGpPWpGaD
Nabilone—Pruritus—Methotrexate—breast cancer	3.1e-05	0.000172	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—SPP1—breast cancer	3.09e-05	0.000336	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—CXCL8—breast cancer	3.07e-05	0.000334	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—ERBB3—breast cancer	3.05e-05	0.000332	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—FGFR2—breast cancer	3.05e-05	0.000332	CbGpPWpGaD
Nabilone—Hypersensitivity—Epirubicin—breast cancer	3.02e-05	0.000168	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—MAPK3—breast cancer	3.01e-05	0.000327	CbGpPWpGaD
Nabilone—Body temperature increased—Doxorubicin—breast cancer	3e-05	0.000167	CcSEcCtD
Nabilone—Abdominal pain—Doxorubicin—breast cancer	3e-05	0.000167	CcSEcCtD
Nabilone—Diarrhoea—Methotrexate—breast cancer	3e-05	0.000167	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—BRAF—breast cancer	2.95e-05	0.000321	CbGpPWpGaD
Nabilone—Asthenia—Epirubicin—breast cancer	2.94e-05	0.000164	CcSEcCtD
Nabilone—CNR1—Signaling by GPCR—IL2—breast cancer	2.94e-05	0.00032	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—TERT—breast cancer	2.93e-05	0.000318	CbGpPWpGaD
Nabilone—Pruritus—Epirubicin—breast cancer	2.9e-05	0.000161	CcSEcCtD
Nabilone—Dizziness—Methotrexate—breast cancer	2.9e-05	0.000161	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—IGF1—breast cancer	2.88e-05	0.000313	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—AKT2—breast cancer	2.87e-05	0.000313	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—EGFR—breast cancer	2.86e-05	0.000311	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—FGFR1—breast cancer	2.84e-05	0.000309	CbGpPWpGaD
Nabilone—Diarrhoea—Epirubicin—breast cancer	2.81e-05	0.000156	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—HIF1A—breast cancer	2.8e-05	0.000304	CbGpPWpGaD
Nabilone—Hypersensitivity—Doxorubicin—breast cancer	2.8e-05	0.000155	CcSEcCtD
Nabilone—Vomiting—Methotrexate—breast cancer	2.79e-05	0.000155	CcSEcCtD
Nabilone—Rash—Methotrexate—breast cancer	2.76e-05	0.000154	CcSEcCtD
Nabilone—Dermatitis—Methotrexate—breast cancer	2.76e-05	0.000153	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—PIK3CD—breast cancer	2.76e-05	0.000301	CbGpPWpGaD
Nabilone—Headache—Methotrexate—breast cancer	2.75e-05	0.000153	CcSEcCtD
Nabilone—CNR2—GPCR downstream signaling—PIK3CA—breast cancer	2.73e-05	0.000298	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—SERPINE1—breast cancer	2.73e-05	0.000297	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—LEP—breast cancer	2.73e-05	0.000297	CbGpPWpGaD
Nabilone—Asthenia—Doxorubicin—breast cancer	2.72e-05	0.000151	CcSEcCtD
Nabilone—Dizziness—Epirubicin—breast cancer	2.71e-05	0.000151	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—CAV1—breast cancer	2.71e-05	0.000294	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—KRAS—breast cancer	2.7e-05	0.000294	CbGpPWpGaD
Nabilone—Pruritus—Doxorubicin—breast cancer	2.69e-05	0.000149	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—KDR—breast cancer	2.68e-05	0.000291	CbGpPWpGaD
Nabilone—Vomiting—Epirubicin—breast cancer	2.61e-05	0.000145	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—NOS3—breast cancer	2.61e-05	0.000284	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—ESR1—breast cancer	2.61e-05	0.000284	CbGpPWpGaD
Nabilone—Nausea—Methotrexate—breast cancer	2.6e-05	0.000145	CcSEcCtD
Nabilone—Diarrhoea—Doxorubicin—breast cancer	2.6e-05	0.000144	CcSEcCtD
Nabilone—Rash—Epirubicin—breast cancer	2.59e-05	0.000144	CcSEcCtD
Nabilone—Dermatitis—Epirubicin—breast cancer	2.58e-05	0.000144	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—FN1—breast cancer	2.58e-05	0.00028	CbGpPWpGaD
Nabilone—Headache—Epirubicin—breast cancer	2.57e-05	0.000143	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—NFKBIA—breast cancer	2.54e-05	0.000277	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—NOTCH1—breast cancer	2.52e-05	0.000274	CbGpPWpGaD
Nabilone—Dizziness—Doxorubicin—breast cancer	2.51e-05	0.000139	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—PIK3CA—breast cancer	2.48e-05	0.00027	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—MDM2—breast cancer	2.47e-05	0.000269	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—RAF1—breast cancer	2.46e-05	0.000268	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PIK3CG—breast cancer	2.46e-05	0.000268	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—KIT—breast cancer	2.46e-05	0.000268	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—APC—breast cancer	2.46e-05	0.000268	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—RELA—breast cancer	2.45e-05	0.000267	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—ERBB2—breast cancer	2.44e-05	0.000265	CbGpPWpGaD
Nabilone—Nausea—Epirubicin—breast cancer	2.44e-05	0.000135	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—EGF—breast cancer	2.44e-05	0.000265	CbGpPWpGaD
Nabilone—Vomiting—Doxorubicin—breast cancer	2.41e-05	0.000134	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—MTOR—breast cancer	2.41e-05	0.000262	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PIK3CB—breast cancer	2.41e-05	0.000262	CbGpPWpGaD
Nabilone—Rash—Doxorubicin—breast cancer	2.39e-05	0.000133	CcSEcCtD
Nabilone—Dermatitis—Doxorubicin—breast cancer	2.39e-05	0.000133	CcSEcCtD
Nabilone—Headache—Doxorubicin—breast cancer	2.38e-05	0.000132	CcSEcCtD
Nabilone—CNR1—Signaling by GPCR—MAPK3—breast cancer	2.36e-05	0.000257	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—BRAF—breast cancer	2.32e-05	0.000252	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CXCL8—breast cancer	2.31e-05	0.000252	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—HRAS—breast cancer	2.3e-05	0.00025	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CDKN1B—breast cancer	2.26e-05	0.000246	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—IGF1—breast cancer	2.26e-05	0.000246	CbGpPWpGaD
Nabilone—Nausea—Doxorubicin—breast cancer	2.26e-05	0.000125	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—AKT2—breast cancer	2.25e-05	0.000245	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—EGFR—breast cancer	2.25e-05	0.000244	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—AKT1—breast cancer	2.23e-05	0.000243	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CASP3—breast cancer	2.21e-05	0.000241	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—IL2—breast cancer	2.21e-05	0.000241	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—IL6—breast cancer	2.2e-05	0.000239	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PIK3CD—breast cancer	2.17e-05	0.000236	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CCND1—breast cancer	2.15e-05	0.000235	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—JUN—breast cancer	2.15e-05	0.000234	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—PIK3CA—breast cancer	2.15e-05	0.000234	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—SERPINE1—breast cancer	2.14e-05	0.000233	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CTNNB1—breast cancer	2.13e-05	0.000232	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—KRAS—breast cancer	2.12e-05	0.000231	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—MMP9—breast cancer	2.09e-05	0.000228	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CDKN1A—breast cancer	2.08e-05	0.000227	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PTEN—breast cancer	2.08e-05	0.000226	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—NOS3—breast cancer	2.05e-05	0.000223	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—MAPK8—breast cancer	2.03e-05	0.000221	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—AKT1—breast cancer	2.03e-05	0.000221	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—PIK3CA—breast cancer	1.95e-05	0.000212	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—MDM2—breast cancer	1.94e-05	0.000211	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—RAF1—breast cancer	1.93e-05	0.000211	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—SRC—breast cancer	1.93e-05	0.00021	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—RELA—breast cancer	1.93e-05	0.00021	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—ERBB2—breast cancer	1.91e-05	0.000208	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—MTOR—breast cancer	1.89e-05	0.000206	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PIK3CB—breast cancer	1.89e-05	0.000206	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—VEGFA—breast cancer	1.88e-05	0.000204	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—STAT3—breast cancer	1.86e-05	0.000202	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CXCL8—breast cancer	1.81e-05	0.000198	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—HRAS—breast cancer	1.8e-05	0.000196	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—MAPK3—breast cancer	1.78e-05	0.000193	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CDKN1B—breast cancer	1.77e-05	0.000193	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—AKT1—breast cancer	1.75e-05	0.000191	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CASP3—breast cancer	1.74e-05	0.000189	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—IL2—breast cancer	1.73e-05	0.000189	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—MYC—breast cancer	1.73e-05	0.000188	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—IL6—breast cancer	1.73e-05	0.000188	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—TGFB1—breast cancer	1.72e-05	0.000188	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CCND1—breast cancer	1.69e-05	0.000184	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—EGFR—breast cancer	1.69e-05	0.000184	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—JUN—breast cancer	1.69e-05	0.000184	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CTNNB1—breast cancer	1.67e-05	0.000182	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—MMP9—breast cancer	1.64e-05	0.000179	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CDKN1A—breast cancer	1.64e-05	0.000178	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PTEN—breast cancer	1.63e-05	0.000178	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—KRAS—breast cancer	1.6e-05	0.000174	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—MAPK8—breast cancer	1.6e-05	0.000174	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—AKT1—breast cancer	1.59e-05	0.000173	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—SRC—breast cancer	1.51e-05	0.000165	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—VEGFA—breast cancer	1.47e-05	0.00016	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PIK3CA—breast cancer	1.47e-05	0.00016	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—STAT3—breast cancer	1.46e-05	0.000159	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—TP53—breast cancer	1.42e-05	0.000154	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—MAPK3—breast cancer	1.39e-05	0.000152	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—HRAS—breast cancer	1.36e-05	0.000148	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—MYC—breast cancer	1.36e-05	0.000148	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—TGFB1—breast cancer	1.35e-05	0.000147	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—EGFR—breast cancer	1.33e-05	0.000144	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—IL6—breast cancer	1.3e-05	0.000141	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—KRAS—breast cancer	1.25e-05	0.000136	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—AKT1—breast cancer	1.2e-05	0.00013	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PIK3CA—breast cancer	1.15e-05	0.000125	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—TP53—breast cancer	1.11e-05	0.000121	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—HRAS—breast cancer	1.07e-05	0.000116	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—IL6—breast cancer	1.02e-05	0.000111	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—AKT1—breast cancer	9.4e-06	0.000102	CbGpPWpGaD
